$0.4103
-0.0322-7.28%

The average analyst price target for Inuvo is $9.60. Of 4 analysts, 4 rate it Buy. Targets range from $4 to $20. The latest change came on Jul 8, 2026, when Ladenburg Thalmann lowered its price target on Inuvo from $4.25 to $4 and kept a Buy rating.
Price Target Range — 7 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months